GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharmaceutical Co Ltd (XKRX:271980) » Definitions » YoY EPS Growth

Jeil Pharmaceutical Co (XKRX:271980) YoY EPS Growth : -2.13% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Jeil Pharmaceutical Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Jeil Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Sep. 2024 was -2.13%.

Jeil Pharmaceutical Co's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was ₩-288.00.

Jeil Pharmaceutical Co YoY EPS Growth Historical Data

The historical data trend for Jeil Pharmaceutical Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharmaceutical Co YoY EPS Growth Chart

Jeil Pharmaceutical Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial -591.55 167.77 -280.55 -5.15 138.20

Jeil Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.05 37.65 -122.59 -1,855.91 -2.13

Jeil Pharmaceutical Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Jeil Pharmaceutical Co's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(343--898)/ | -898 |
=138.20 %

Jeil Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EPS Growth (Q: Sep. 2024 )
=(Earnings per Share (Diluted) (Q: Sep. 2024 )-Earnings per Share (Diluted) (Q: Sep. 2023 )) / | Earnings per Share (Diluted) (Q: Sep. 2023 )) |
=(-288--282)/ | -282 |
=-2.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jeil Pharmaceutical Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Jeil Pharmaceutical Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeil Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharmaceutical Co Ltd (XKRX:271980) » Definitions » YoY EPS Growth
Comparable Companies
XKRX:003060 XKRX:256840 XKRX:016580 XKRX:293480 XKRX:096760 XKRX:220100 XKRX:234080 XKRX:001630 XKRX:007570 XKRX:084110 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
343, Sapyeong-daero, Seocho-gu, Seoul, KOR, 06543
Website
https://www.jeilpharm.co.kr
Jeil Pharmaceutical Co Ltd is engaged in maufacturing and distribution of pharmaceutical products. The company's products include antibiotics, anti-inflammatory painkillers, hepatitis remedies, duodenum ulcer treatments, and anticancer drugs.

Jeil Pharmaceutical Co Headlines

No Headlines